Incidence and risk factors of nephritis in childhood Henoch-Schonlein purpura

IF 0.2 Q4 PEDIATRICS Paediatrica Indonesiana Pub Date : 2023-08-28 DOI:10.14238/pi63.4.2023.304-14
Yaulia Yanrismet, E. Hidayati, Z. Munasir, Klara Yuliarti, Afifa Fahriyani
{"title":"Incidence and risk factors of nephritis in childhood Henoch-Schonlein purpura","authors":"Yaulia Yanrismet, E. Hidayati, Z. Munasir, Klara Yuliarti, Afifa Fahriyani","doi":"10.14238/pi63.4.2023.304-14","DOIUrl":null,"url":null,"abstract":"Background Henoch-Schönlein Purpura (HSP) is the most common systemic vasculitis disease in children. It is characterized by involvement of the skin, joints, gastrointestinal tract, and kidney. Kidney manifestations may progress to severe nephritis, even lead to end-stage kidney disease. \nObjective To identify the incidence and risk factors of nephritis in childhood HSP. \nMethods A retrospective cohort study was performed to evaluate clinical, demographic, laboratory, and therapeutic parameters of HSP patients aged 0-18 years between 2011-2019 at Dr. Cipto Mangunkusumo Hospital, Jakarta. Diagnoses of HSP were made according to the 2008 EULAR/PRES/PRINTO criteria. Wefollowed subjects’ medical records for at least 3 months after disease onset to observe incidence and risk factors of Henoch-Schönlein nephritis (HSN).Results There were 112 HSP patients (aged 2-17 years) included in this study. HSN was found in 40 out of 112 patients (35.7%). Nephritis developed within the first 4 weeks for a majority of cases. Multivariate analysis showed that persistent purpura (OR 3.306; 95%CI 1.315 to 8.315; P=0.011) and acute phase leukocytosis(OR 2.585; 95%CI 1.047 to 6.385; P=0.039) were significantly associated risk factors for HSN. We found that corticosteroid use did not reduce the risk of HSN. The accumulation of several risk factors was associated with the likelihood of developing HSN. \nConclusion Persistent purpura and acute phase leukocytosis are independent risk factors for HSN. Therefore, blood tests are needed to estimate the risk of HSN. Early corticosteroid therapy do not reduce the risk of kidney impairment.","PeriodicalId":19660,"journal":{"name":"Paediatrica Indonesiana","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2023-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Paediatrica Indonesiana","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14238/pi63.4.2023.304-14","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background Henoch-Schönlein Purpura (HSP) is the most common systemic vasculitis disease in children. It is characterized by involvement of the skin, joints, gastrointestinal tract, and kidney. Kidney manifestations may progress to severe nephritis, even lead to end-stage kidney disease. Objective To identify the incidence and risk factors of nephritis in childhood HSP. Methods A retrospective cohort study was performed to evaluate clinical, demographic, laboratory, and therapeutic parameters of HSP patients aged 0-18 years between 2011-2019 at Dr. Cipto Mangunkusumo Hospital, Jakarta. Diagnoses of HSP were made according to the 2008 EULAR/PRES/PRINTO criteria. Wefollowed subjects’ medical records for at least 3 months after disease onset to observe incidence and risk factors of Henoch-Schönlein nephritis (HSN).Results There were 112 HSP patients (aged 2-17 years) included in this study. HSN was found in 40 out of 112 patients (35.7%). Nephritis developed within the first 4 weeks for a majority of cases. Multivariate analysis showed that persistent purpura (OR 3.306; 95%CI 1.315 to 8.315; P=0.011) and acute phase leukocytosis(OR 2.585; 95%CI 1.047 to 6.385; P=0.039) were significantly associated risk factors for HSN. We found that corticosteroid use did not reduce the risk of HSN. The accumulation of several risk factors was associated with the likelihood of developing HSN. Conclusion Persistent purpura and acute phase leukocytosis are independent risk factors for HSN. Therefore, blood tests are needed to estimate the risk of HSN. Early corticosteroid therapy do not reduce the risk of kidney impairment.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
儿童过敏性紫癜肾炎的发病率及危险因素分析
背景Henoch-Schönlein紫癜(HSP)是儿童最常见的全身性血管炎。它的特点是累及皮肤、关节、胃肠道和肾脏。肾脏表现可发展为严重的肾炎,甚至导致终末期肾脏疾病。目的探讨儿童HSP肾炎的发病率及危险因素。方法采用回顾性队列研究,评估雅加达Dr. Cipto Mangunkusumo医院2011-2019年0-18岁HSP患者的临床、人口学、实验室和治疗参数。根据2008年EULAR/PRES/PRINTO标准诊断热休克。我们随访受试者发病后至少3个月的病历,观察Henoch-Schönlein肾炎(HSN)的发生率及危险因素。结果本研究共纳入112例HSP患者,年龄2 ~ 17岁。112例患者中有40例(35.7%)出现HSN。大多数病例在最初4周内出现肾炎。多因素分析显示持续性紫癜(OR 3.306;95%CI 1.315 ~ 8.315;P=0.011)和急性期白细胞增多(OR 2.585;95%CI 1.047 - 6.385;P=0.039)是HSN的显著相关危险因素。我们发现皮质类固醇的使用并没有降低HSN的风险。几种危险因素的积累与发生HSN的可能性有关。结论持续性紫癜和急性期白细胞增多是HSN的独立危险因素。因此,需要血液检查来评估HSN的风险。早期皮质类固醇治疗不能降低肾脏损害的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.40
自引率
0.00%
发文量
58
审稿时长
24 weeks
期刊最新文献
Complete atrioventricular block in an adolescent with acute rheumatic fever: a case report Shared medical appointments and quality of life for children with HIV-AIDS Effects of non-pharmacological methods on post-operative procedural pain management in neonates admitted in the neonatal intensive care unit: A systematic review Challenges in the management of pediatric ruptured brain arteriovenous malformation: a case report Gestational age, birth weight, and blood culture microbial patterns in late-onset neonatal sepsis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1